Back
~
1
min read
· Posted on
February 21, 2024

No more waiting at the counter as Chemist Warehouse prescribes itself a reverse listing on the ASX

Chemist Warehouse is looking likely to list on the ASX via a reverse listing of Sigma Healthcare.

What's the key learning?

  • Chemist Warehouse has had a whole heap of challenges due to ownership restrictions in the pharmacy industry.
  • A reverse listing is a way for a company to get on the stock exchange by going through a back door.
  • By doing this, Chemist Warehouse can bypass the lengthy and complex process of going public.

👉 Background: Chemist Warehouse opened its first store in Melbourne with the idea of turning a pharmacy into a retail experience. Low margin, high volume. And since then, it has grown to over 500 stores in Australia and generated $3.1 billion of revenue in the last financial year.

👉 What happened: Now, Chemist Warehouse is looking likely to list on the ASX via a reverse listing of Sigma Healthcare, of which Chemist Warehouse already owns 10%.

👉 What else: Many investors have been licking their lips about the eventual IPO of Chemist Warehouse. But, Chemist Warehouse has had a whole heap of challenges due to ownership restrictions in the pharmacy industry.

What's the key learning?

💡A reverse listing is a way for a private company to go public. It's a way for a company to get on the stock exchange by going through a back door.

💡 By doing this, Chemist Warehouse can bypass the lengthy and complex process of going public. Think: investor roadshows, investment memorandums and complex listing requirements.

💡It's believed that the new merged company will be valued around $8 billion. Right now, Sigma Healthcare's valuation is around $780 million. So Chemist Warehouse will be the large bulk of the value in this merged entity.

Ready to win at money?

Sign up for Flux and join 100,000 members of the Flux family

A button to App StoreGoogle Play store button
Excellent  4.9 out of 5
Star rating